Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates

Opyl has reached a major milestone with its latest software solution TrialKey that offers enormous commercial potential for the company but could also be a game-changer in clinical trials globally.

“TrialKey is a world-first approach using artificial intelligence (AI) to design and optimise clinical trial protocols to overcome the trial outcome data gap.”

“TrialKey has traced global clinical trials to their outcomes with 92% accuracy, reducing bias in the predictive model.”

Read the article on Stockhead: https://stockhead.com.au/health/opyls-trialkey-achieves-major-milestone-with-potential-to-improve-clinical-trial-success-rates/